Robert Benjamin Stein's Net Worth
$880 Thousand
Who is Robert Benjamin Stein?
Robert Benjamin Stein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MIMEDX GROUP, INC., AGENUS INC, and Protagenic Therapeutics, Inc.\new.
SEC CIK
Robert Benjamin Stein's CIK is 0001597158
Past Insider Trading and Trends
2016 was Robert Benjamin Stein's most active year for acquiring shares with 6 total transactions. Robert Benjamin Stein's most active month to acquire stocks was the month of February. 2023 was Robert Benjamin Stein's most active year for disposing of shares, totalling 7 transactions. Robert Benjamin Stein's most active month to dispose stocks was the month of April. 2016 saw Robert Benjamin Stein paying a total of $1,417,040.75 for 402,805 shares, this is the most they've acquired in one year. In 2023 Robert Benjamin Stein cashed out on 95,935 shares for a total of $489,752.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MIMEDX GROUP, INC. (MDXG) Snapshot price: $6.15
President, Regenerative Med.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.21% | -13.97K |
$6.00 | -$83,797.61 | 317.8K |
May 15 - May 16
| |||
Form 4
| -1.74% | -5.87K |
$5.93 | -$34,780.28 | 331.77K |
May 10
| |||
Form 4
| -13.29% | -51.76K |
$5.34 | -$276,470.20 | 337.64K |
May 4
| |||
Form 4
| -1.51% | -5.99K |
$3.74 | -$22,415.33 | 389.4K |
Apr 25
| |||
Form 4
| -1.49% | -6.00K |
$3.31 | -$19,846.76 | 395.39K |
Apr 11
| |||
Form 4
| +50.72% | 135.06K |
$4.62 | $624,000.30 | 401.38K |
Mar 13
| |||
Form 4
| -4.43% | -12.36K |
$4.24 | -$52,442.03 | 266.32K |
Mar 7
| |||
Form 4
| -8.93% | -27.33K |
$3.44 | -$94,069.02 | 278.67K |
Sep 12 - Sep 13
| |||
Form 4
| -2.70% | -8.50K |
$4.04 | -$34,343.62 | 306K |
Aug 12
| |||
Form 4
| -5.84% | -19.50K |
$3.62 | -$70,590.00 | 314.5K |
Aug 4
| |||
Form 4
| -4.19% | -14.60K |
$3.47 | -$50,662.00 | 334K |
Jun 28
| |||
Form 4
| +105.02% | 178.57K |
$4.62 | $824,998.02 | 348.61K |
Apr 8
| |||
Form 4
| -6.42% | -11.67K |
$4.86 | -$56,714.25 | 170.03K |
Mar 8
| |||
Form 4
| -4.90% | -9.36K |
$11.85 | -$110,967.79 | 181.71K |
Aug 16
| |||
Form 4
| +133.49% | 109.23K |
—
|
—
| 191.07K |
Mar 4
| |||
Form 4
|
∞
| 81.83K |
$6.11 | $499,999.63 | 81.83K |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGENUS INC (AGEN) Snapshot price: $4.95
President R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
∞
| 45.76K |
$4.15 | $189,920.60 | 20.99K |
Apr 26
| |||
Form 4
|
∞
| 20.78K |
$4.15 | $86,220.40 | 20.78K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagenic Therapeutics, Inc.\new (PTIX) Snapshot price: $0.7888
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
| +20.00% | 40K |
$1.25 | $50,000.00 | 240K |
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||